Iktos

Iktos pioneers AI and robotics for drug discovery, offering an integrated platform that transforms the development of new treatments. Their core offerings include Makya, a generative AI platform for molecular design, and Spaya, an AI-driven retrosynthesis tool, both designed to accelerate the DMTA cycle. Iktos serves chemists and researchers by providing solutions for innovative molecular design, efficient synthesis planning, and fully automated laboratory processes.